We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ipso Ventures | LSE:IPS | London | Ordinary Share | GB00B1GDWB47 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.425 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
22/2/2012 09:58 | just bought another 65k no probs, averaging down | aw328 | |
22/2/2012 09:13 | and a 3 x 25k buyer followed me. MM's have to quickly adjust the share price as it is a highly illiquid stock. The time to be buying is when we are waiting for a portfolio update......like now! | howdlep | |
22/2/2012 09:07 | One or two sellers today in a very thin market. However, the story is unchanged so I have picked up a few and will add further on additional weakness. | howdlep | |
13/2/2012 10:10 | with this share being illiquid and with a tiny market cap, it is going to be very difficult for anyone to pick up qty in size, unless they pay a premium. MM's are going to have to encourage sellers by moving the share price up, so expect 4p to be taken out shortly | howdlep | |
13/2/2012 10:08 | Yes 4p is the key level, a break of which could see some serious upside. | matt123d | |
13/2/2012 10:02 | here we go. 4p test coming up and then this one will really move | howdlep | |
13/2/2012 10:02 | Definitely MMs moving the price around to fill an order. | matt123d | |
13/2/2012 10:01 | maytrees, When the offer drops with the bid then I would agree with your supply comment. However, for the last couple of trading days you have been able to sell in size at the mid price but buy very little online. With a few buys this is going over 4p initial resistance in short time. | howdlep | |
13/2/2012 09:58 | telephone buy - had to pay 3.50p and share price then ticked up anyway - so why the initial tick down if not MMs' games? | maytrees | |
13/2/2012 09:46 | Irritating to see that my buy order not filled atm. Are MMs playing gamesand if so why? Reducing share price suggests more supply than demand for IPS shares yet you cannot buy online even for ready money | maytrees | |
13/2/2012 09:16 | Greetings howdlep You may be right - I sipped a few more at 3.25p but then online buying was halted. Selling online however is fine and a dummy quote gives c.3.18p bid share price compared with published bid of 2.75p - dyor I hold EDIT No online quote for 18,000 IPS shares so put in limit buy order at 3.25p. | maytrees | |
13/2/2012 08:50 | MM's trying to scare one or two into selling. Now lets see if buyers take advantage of the opportunity. I would expect the bid to move back up quickly | howdlep | |
10/2/2012 12:12 | howl - I'm really positive about the prosepcts here, especially Therakind. Once we get some news flowing I can only see a mjaor rerating. Just checked and they will now take 1m off your hands online. For 250k they'll pay 3.29. Can't remember the last time I saw a small fairly illiquid stock like this where you could sell getting on for 3% of the co in one trade online. | bobs good eye | |
10/2/2012 11:06 | o/t if anyone wants to investigate what is my biggest holding then checkout the COMS thread | howdlep | |
10/2/2012 10:57 | Bobs Good Eye, Yep the mm's can keep a wide spread all they like, but they are not going to encourage sellers even at the mid. Once we break above 4p the fun will really begin. As you say, the buy and sell limits say it all. | howdlep | |
10/2/2012 10:15 | thanks howdlep looking promising already. | pezza4 | |
10/2/2012 08:48 | pezza4, Excellent purchase imo. I am expecting value enhancing news from three of IPS' investments in due course, namely Biocroi, IPSol Energy and in particular Therakind. For those new to this bb, here is a little about Therakind, taken from the Half Year report:- (note, that one product is at a late stage of development) "Therakind is a paediatric healthcare company. It takes known adult drugs and creates a version for children which can be protected by EU legislation. The revenue model is to generate royalties on product sales. Therakind's major success in 2011 was the securing of the first PUMA (Paediatric Use Marketing Authorisation) for its first product, Buccolam. This product has been licenced to Viropharma Inc who have launched the product in the UK to be followed by launches in other European countries. Therakind has received certain upfront payments and will receive royalties on sales of Buccolam. Therakind is co-developing a pipeline of products with a number of partners. These products are at various stages of development and include one which is in late stage development. Therakind is based in London and other investors include University College London, private investors, management and the academic founder. IPSO's shareholding is 36%" | howdlep | |
10/2/2012 08:43 | howl - it's hard enough to get stock in size now. Buy limit 75k online @ 3.4p but you can sell up to 850k. For smaller size they'll pay over mid price. | bobs good eye | |
10/2/2012 08:26 | i'm in for 60k like the story great potential. | pezza4 | |
10/2/2012 08:23 | First tickup after the third buy of the morning. This could move very quickly now | howdlep | |
10/2/2012 07:48 | This is a micro cap and as such is very illiquid. The pi has to buy stock ahead of the expected good news, as the share price will gap up and it will be almost impossible to buy qty in any decent size. Once resistance at 4p is broken, expect momentum to really build. | howdlep | |
10/2/2012 07:44 | No 7am RNS. Excellent. A chance to grab a few more before the herd arrives. | kablinsky | |
09/2/2012 12:05 | wrong thread | zico01 | |
09/2/2012 11:41 | A little bit of profit taking now out of the way, we can now move to test and climb above resistance at 4p. This one has a long way to run imo, as management look to realise value from its investments. Exciting times ahead. | howdlep |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions